Anlotinib: A Promising Therapeutic Approach for Transformed Follicular Lymphoma
Introduction: Transformed follicular lymphoma (tFL) presents a formidable challenge in clinical oncology due to its high tumor mutational burden and therapeutic resistance. While anlotinib has demonstrated efficacy in solid tumors,…
